| J0897 | Injection, denosumab, 1 mg | 19,740 | $20 | $355.3K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,930 | $30 | $261.8K |
| J9312 | Injection, rituximab, 10 mg | 3,140 | $60 | $197.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,350 | $10 | $190.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,400 | $30 | $88.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 10,710 | $10 | $85.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 780 | $90 | $69.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 410 | $100 | $40.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 420 | $50 | $21.9K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 660 | $10 | $6.6K |